Transmeta yesterday admitted its sales had fallen by almost half between the second and third quarters of its current fiscal year and almost 60 per cent down on Q3 2002.
The current, fourth quarter isn't going to get any better. Despite launching its new Efficeon processor on Tuesday, Transmeta reckons its sales could halve again at worst - at best, they'll stay the same - with a loss of around 15-17 cents a share. That's excluding $3 million worth of non-cash amortization and deferred compensation charges.
Read more: The Register.
The current, fourth quarter isn't going to get any better. Despite launching its new Efficeon processor on Tuesday, Transmeta reckons its sales could halve again at worst - at best, they'll stay the same - with a loss of around 15-17 cents a share. That's excluding $3 million worth of non-cash amortization and deferred compensation charges.
Read more: The Register.
